DATABASE

Name	Category
iCo Therapeutics Announces First Quarter 2013 Financial Results	News
iCo Therapeutics Announces Overnight Marketed Equity Offering	News
iCo Therapeutics Announces Positive iCo-007 Phase 2 Clinical Update - Provides Additional Guidance on Study Timelines and Further Updates -	News
iCo Therapeutics Announces Third Quarter 2012 Financial Results	News
iCo Therapeutics Announces Year End 2012 Financial Results	News
iCo Therapeutics Closes $3.4 Million Financing	News
iCo Therapeutics Grants Options to Directors, Officers and Employees	News
ICO Therapeutics Inc.	Fund
iCo Therapeutics Ranked Number One in Technology & Life Sciences on 2013 TSX Venture 50	News
iCo Therapeutics to Present at the 15th Annual BIO CEO & Investor Conference	News
iCo Therapeutics to Present at the Bloom Burton & Co. Healthcare Investor Conference	News
iCo Therapeutics to Raise $3.2 Million	News
iCo Therapeutics` Oral Amphotericin B Delivery System to be Presented at AAPS with Updated Patent Position	News
ICON	Company
Icon Advisers Incorporated	Company
ICON appoints new senior executive to head up its golf event operations	News
ICON Asia-Pacific Region S	Fund
ICON Bond C	Fund
ICON Consumer Discretionary S	Fund
ICON Consumer Staples S	Fund
ICON Core Equity I	Fund
ICON Energy C	Fund
Icon Energy Limited	Fund
Icon Energy Limited (ASX:ICN) Advises Keppel -1 Unconventional Shale Gas Well Spuds	News
Icon Energy Limited (ASX:ICN) Advises Keppel -1 Unconventional Shale Gas Well Spuds	News

Page 29 of 354